Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.
作者信息
Unal S, Hayran M, Tuncer S, Gür D, Uzun O, Akova M, Akalin H E
机构信息
Department of Internal Medicine, School of Medicine, Hacettepe University, Ankara, Turkey.
出版信息
Antimicrob Agents Chemother. 1996 Dec;40(12):2898-900. doi: 10.1128/AAC.40.12.2898.
Abstract
In this prospective study of enteric fever, 22 patients received 400 mg of pefloxacin twice daily for 5 days (group A) and 24 received 400 mg of pefloxacin twice daily for 7 days (group B). Causative microorganisms were Salmonella typhi (8 in group A, 11 in group B) and Salmonella paratyphi B (14 in group A, 13 in group B). The clinical cure and bacterial eradication rates were 96% (21 of 22) in group A and 100% in group B. In conclusion, 5-day oral administration of pefloxacin was as effective as 7-day treatment of enteric fever caused by Salmonella spp.
摘要
相似文献
1
Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.
Antimicrob Agents Chemother. 1996 Dec;40(12):2898-900. doi: 10.1128/AAC.40.12.2898.
2
Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.
Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):361-3. doi: 10.1007/BF01962337.
3
Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella.
Am J Trop Med Hyg. 1995 Sep;53(3):306-11. doi: 10.4269/ajtmh.1995.53.306.
4
Comparison of two regimens for ciprofloxacin treatment of enteric infections.
Eur J Clin Microbiol Infect Dis. 1997 Nov;16(11):803-6. doi: 10.1007/BF01700409.
5
Short course quinolone therapy of typhoid fever in developing countries.
Drugs. 1995;49 Suppl 2:136-8. doi: 10.2165/00003495-199500492-00022.
6
Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
BMC Infect Dis. 2004 Sep 20;4:36. doi: 10.1186/1471-2334-4-36.
7
[Typhoid and paratyphoid fever].
Z Gastroenterol. 2020 Feb;58(2):160-170. doi: 10.1055/a-1063-1945. Epub 2020 Feb 12.
8
A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.
Support Care Cancer. 1994 May;2(3):191-6. doi: 10.1007/BF00417480.
9
Typhoid fevers: treatment with lomefloxacin.
J Pak Med Assoc. 1998 Jun;48(6):168-70.
10
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model.
PLoS Negl Trop Dis. 2019 Dec 26;13(12):e0007955. doi: 10.1371/journal.pntd.0007955. eCollection 2019 Dec.
引用本文的文献
1
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.
Clin Microbiol Rev. 2015 Oct;28(4):901-37. doi: 10.1128/CMR.00002-15.
2
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).
Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD004530. doi: 10.1002/14651858.CD004530.pub4.
3
Quinolones in the treatment of typhoid fever.
Drugs. 1999;58 Suppl 2:52-4. doi: 10.2165/00003495-199958002-00010.
本文引用的文献
1
Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children.
Antimicrob Agents Chemother. 1996 Apr;40(4):958-61. doi: 10.1128/AAC.40.4.958.
2
Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.
Antimicrob Agents Chemother. 1994 Aug;38(8):1716-20. doi: 10.1128/AAC.38.8.1716.
3
[Evaluation of the use of ofloxacin in the treatment of various infections].
Pathol Biol (Paris). 1986 May;34(5):471-5.
4
Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones.
Rev Infect Dis. 1986 Mar-Apr;8(2):189-207. doi: 10.1093/clinids/8.2.189.
5
Ofloxacin in treatment of typhoid fever: a preliminary study.
J Antimicrob Chemother. 1988 May;21(5):681-2. doi: 10.1093/jac/21.5.681.
6
Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.
Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):361-3. doi: 10.1007/BF01962337.
7
Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of Salmonella enteric fever.
Infection. 1989 Mar-Apr;17(2):105-6. doi: 10.1007/BF01646892.
8
General considerations in the management of typhoid fever and dysentery.
Scand J Gastroenterol Suppl. 1989;169:11-8. doi: 10.3109/00365528909091326.
9
The efficacy and safety of pefloxacin in the treatment of typhoid fever in Algeria.
J Antimicrob Chemother. 1990 Oct;26 Suppl B:181-6. doi: 10.1093/jac/26.suppl_b.181.
Zotero 插件